Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors

Bibliographic Details
Main Authors:	Takahiro Einama, Futoshi Kawamata, Hirofumi Kamachi, Hiroshi Nishihara, Shigenori Homma, Fumihiko Matsuzawa, Tatsuzo Mizukami, Yuji Konishi, Toshiya Kamiyama, Junji Yamamoto, Akinobu Taketomi, Satoru Todo
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417303870

Similar Items

Targeting mesothelin in cancer
by: Cem Elbi
Published: (2023-12-01)

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin
by: Daniel Snell, et al.
Published: (2023-12-01)

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
by: Michel Fausther, et al.
Published: (2017-01-01)

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
by: Yu Yi, et al.
Published: (2011-07-01)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
by: Xianyu Zhang, et al.
Published: (2022-07-01)

Validity of mesothelin in occupational medicine practice
by: Dirk Taeger, et al.
Published: (2016-12-01)

Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
by: Ida Lin, et al.
Published: (2023-08-01)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01)

Mesothelin methylation, soluble mesothelin related protein levels and inflammation profiling in workers chronically exposed to naturally occurring asbestos fibers
by: Caterina Ledda, et al.
Published: (2024-02-01)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
by: Takahiro Nishio, et al.
Published: (2022-10-01)

Mesothelin Gene Variants Affect Soluble Mesothelin-Related Protein Levels in the Plasma of Asbestos-Exposed Males and Mesothelioma Patients from Germany
by: Hans-Peter Rihs, et al.
Published: (2022-12-01)

Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas
by: Rina Nabeta, et al.
Published: (2024-09-01)

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes
by: Song-Hee Han, et al.
Published: (2017-03-01)

Inhibition of mesothelin as a novel strategy for targeting cancer cells.
by: Kun Wang, et al.
Published: (2012-01-01)

The Clinical Role and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions.
by: Davies, H, et al.
Published: (2009)

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
by: Davies, H, et al.
Published: (2009)

Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
by: Erica Torchiaro, et al.
Published: (2024-12-01)

Application of CAR-T cell therapy targeting mesothelin in solid tumor treatment
by: Qiuhong Chen, et al.
Published: (2024-07-01)

Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors
by: Gui-Zhen Zhang, et al.
Published: (2019-05-01)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01)

Simultaneous detection of CA-125 and mesothelin by gold nanoparticles in surface plasmon resonance
by: Erenildo Ferreira de Macedo, et al.
Published: (2024-02-01)

Mesothelin-targeted MRI for assessing migration, invasion, and prognosis in malignant pleural mesothelioma
by: Yilong Huang, et al.
Published: (2024-01-01)

Development of a quartz crystal microbalance-based immunosensor for the early detection of mesothelin in cancer
by: Hem C. Joshi, et al.
Published: (2023-01-01)

Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET
by: Shengkai Xia, et al.
Published: (2024-04-01)

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
by: Jing Guo, et al.
Published: (2024-04-01)

ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells
by: David Mai, et al.
Published: (2024-02-01)

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
by: Sören Weidemann, et al.
Published: (2021-04-01)

Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies
by: Abdennour Benloucif, et al.
Published: (2023-06-01)

Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders
by: Eun-Kee Park, et al.
Published: (2020-12-01)

Assessment of the value of mesothelin in differentiating between different pleural malignancies by different interventional modalities
by: Mona M Ahmed, et al.
Published: (2022-01-01)

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
by: Ivana Kutle, et al.
Published: (2024-12-01)

Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies
by: Briolay T, et al.
Published: (2024-01-01)

333 Empowering cancer immunotherapy by mesothelin-directed CAR T cells engineered to secret checkpoint inhibitors
by: Jiantao Wang, et al.
Published: (2023-11-01)

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
by: Federica Galvagno, et al.
Published: (2024-11-01)

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
by: Ivana Kutle, et al.
Published: (2025-02-01)

Characterization of a re‐engineered, mesothelin‐targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
by: Frieder Bauss, et al.
Published: (2016-10-01)

Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera
by: Adrià Duran, et al.
Published: (2022-08-01)

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer
by: Philippa R. Kennedy, et al.
Published: (2023-02-01)

High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer
by: Suryendu Saha, et al.
Published: (2023-07-01)

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
by: Hua Jiang, et al.
Published: (2017-09-01)